Serum fructosamine is not a useful screening test for gestational diabetes
- 1 February 1991
- journal article
- Published by Elsevier BV in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 38 (3), 217-220
- https://doi.org/10.1016/0028-2243(91)90295-v
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The Role of Serum Fructosamine as a Screening Test for Gestational Diabetes MellitusHormone and Metabolic Research, 1989
- Brief reports with panel discussionAmerican Journal of Obstetrics and Gynecology, 1986
- Serum fructosamine: A screening test for diabetes in pregnancyAmerican Journal of Obstetrics and Gynecology, 1986
- Use of pooled human serum in the standardization process of the serum fructosamine determination for the estimation of glycosylated serum proteinsClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Geographic, Ethnic, and Racial Variations in the Incidence of Gestational Diabetes MellitusDiabetes, 1985
- Screening of High-Risk and General Populations for Gestational Diabetes: Clinical Application and Cost AnalysisDiabetes, 1985
- Screening for Gestational Diabetes: Optimum Timing and Criteria for RetestingDiabetes, 1985
- Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management.BMJ, 1984
- The 24-hour excursion and diurnal rhythm of glucose, insulin, and C-peptide in normal pregnancyAmerican Journal of Obstetrics and Gynecology, 1980
- Screening criteria for high-risk gestational diabetic patientsAmerican Journal of Obstetrics and Gynecology, 1973